ConductScience.org, home

Paper19208577

Graves' disease, rheumatoid arthritis, and anti-tumor necrosis factor-alpha therapy.

Shin JI and 2 others. J Rheumatol, 2009. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Graves' disease, rheumatoid arthritis, and anti-tumor necrosis factor-alpha therapy. Papers, record 19208577. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19208577

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Graves' disease, rheumatoid arthritis, and anti-tumor necrosis factor-alpha therapy.
PubMed
Journal
J Rheumatol
PubMed
Year
2009
PubMed
Publication types
Comment, Letter
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.24
iCite
Revised in PubMed
2015-11-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shin JIJae Il
2Kim MJMin Jung
3Lee JSJae Seung

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
Arthritis, RheumatoidMajor topic
Graves DiseaseMajor topic
Tumor Necrosis Factor-alphaMajor topic
Adalimumab
Adult
Aged
Antibodies, Monoclonal, Humanized
Antirheumatic Agents
Autoantibodies
Autoimmunity
Cross Reactions
Etanercept
Female
Humans
Iatrogenic Disease
Immunoglobulin G
Immunosuppressive Agents
Monitoring, Physiologic
Receptors, Tumor Necrosis Factor
Thyroid Gland

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on18464319Graves' disease in a patient with rheumatoid arthritis during treatment with anti-tumor necrosis factor-alpha.https://conductscience.org/library/papers/18464319

Source PubMed

Download CSV of comments and corrections

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
39224736The Effect of Vitamin D Supplementation on Thyroid Hormone Levels in Patients With Autoimmune Thyroid Disease: A Systematic Review.Cureus2024https://conductscience.org/library/papers/39224736PubMed
33485845Systemic diseases and the cornea.Exp Eye Res2021https://conductscience.org/library/papers/33485845PubMed
28052092The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study.PLoS One2017https://conductscience.org/library/papers/28052092PubMed
23209899Autoimmune thyroid disease in rheumatoid arthritis: a global perspective.Arthritis2012https://conductscience.org/library/papers/23209899PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19208577

GET https://conductscience.org/api/papers/v1/19208577/authors